SCHEMBL3922813

SCHEMBL3922813

O=C(O)N[C@H]1CN(Cc2ccccc2)C[C@H]1N1CCCCC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ ACHE P22303 1/20 0.44
▸ S1PR1 P21453 1/20 0.42
▸ S1PR5 Q9H228 1/20 0.42
▸ DPP7 Q9UHL4 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ SIGMAR1 Q99720 4/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ SCN4A P35499 2/20 0.39
▸ BCHE P06276 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HDAC4 P56524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922808 1.00 L3MBTL1 (0.44) L3MBTL1ACHES1PR1S1PR5DPP7
SCHEMBL3932267 0.97 L3MBTL1 (0.41) L3MBTL1ACHES1PR1S1PR5DPP7
SCHEMBL3932271 0.97 L3MBTL1 (0.41) L3MBTL1ACHES1PR1S1PR5DPP7
SCHEMBL146760 0.86 KMT2A (0.47) L3MBTL1ACHEKMT2ABCHEMAOB
SCHEMBL459673 0.86 KMT2A (0.47) L3MBTL1ACHEKMT2ABCHEMAOB
SCHEMBL146759 0.86 KMT2A (0.47) L3MBTL1ACHEKMT2ABCHEMAOB
SCHEMBL149953 0.82 KMT2A (0.48) L3MBTL1KMT2ADRD2BCHEMAOB
SCHEMBL1721376 0.81 S1PR1 (0.37) L3MBTL1S1PR1S1PR5POLBKMT2A
SCHEMBL3926744 0.81 S1PR1 (0.37) L3MBTL1S1PR1S1PR5POLBKMT2A
SCHEMBL3926747 0.81 S1PR1 (0.37) L3MBTL1S1PR1S1PR5POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7485641-B2 Substituted 3-amino-pyrrolidino-4-lactams PFIZER, INC. (US) 2009-02-03 — — US disclosed
US-20070299076-A1 Substituted 3-Amino-Pyrrolidino-4-Lactams PFIZER INC 2007-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299076-A1 Substituted 3-Amino-Pyrrolidino-4-Lactams PRMT1, PRMT7, PRMT3 L3MBTL1 4488/4885ACHE 2607/4885S1PR1 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback